Case of anterior uveitis after intravitreal injection of bevacizumab.
Pieramici
Dante J
DJ
California Retina Consultants and Research Foundation, Santa Barbara, California 93103, USA. dpieramici@yahoo.com
Avery
Robert L
RL
Castellarin
Alessandro A
AA
Nasir
Ma'an A
MA
Rabena
Melvin
M
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000869:Anterior Eye Segment / Q000187:drug effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy / Q000209:etiology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000188:drug therapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; C009935:prednisolone acetate; D011239:Prednisolone